7.92 USD
+0.03 (+0.38%)
7.92 USD
0 (0%)
BVS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. BVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. BVS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
- BVS had positive earnings in the past year.
- In the past year BVS had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
- BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of BVS (1.11%) is better than 75.54% of its industry peers.
- The Return On Equity of BVS (4.71%) is better than 77.17% of its industry peers.
- The Return On Invested Capital of BVS (6.62%) is better than 80.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BVS has a Profit Margin of 1.39%. This is in the better half of the industry: BVS outperforms 74.46% of its industry peers.
- With a decent Operating Margin value of 8.03%, BVS is doing good in the industry, outperforming 75.54% of the companies in the same industry.
- BVS's Operating Margin has declined in the last couple of years.
- The Gross Margin of BVS (67.76%) is better than 73.37% of its industry peers.
- In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
- BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- BVS has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for BVS has been increased compared to 5 years ago.
- BVS has a better debt/assets ratio than last year.
2.2 Solvency
- BVS has an Altman-Z score of 1.25. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of BVS (1.25) is comparable to the rest of the industry.
- BVS has a debt to FCF ratio of 6.22. This is a slightly negative value and a sign of low solvency as BVS would need 6.22 years to pay back of all of its debts.
- BVS has a better Debt to FCF ratio (6.22) than 76.09% of its industry peers.
- BVS has a Debt/Equity ratio of 1.93. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.93, BVS is not doing good in the industry: 81.52% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.25 |
ROIC/WACC0.6
WACC10.97%
2.3 Liquidity
- A Current Ratio of 1.74 indicates that BVS should not have too much problems paying its short term obligations.
- BVS's Current ratio of 1.74 is on the low side compared to the rest of the industry. BVS is outperformed by 66.85% of its industry peers.
- A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
- BVS's Quick ratio of 1.14 is on the low side compared to the rest of the industry. BVS is outperformed by 70.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 51.28% over the past year.
- BVS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.93% yearly.
- BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.58%.
- BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
- The Earnings Per Share is expected to grow by 25.05% on average over the next years. This is a very strong growth
- Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.58% on average per year.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.42 indicates a correct valuation of BVS.
- Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 91.30% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 28.87. BVS is valued rather cheaply when compared to this.
- Based on the Price/Forward Earnings ratio of 9.86, the valuation of BVS can be described as reasonable.
- BVS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BVS is cheaper than 95.11% of the companies in the same industry.
- BVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.42 | ||
| Fwd PE | 9.86 |
4.2 Price Multiples
- 90.76% of the companies in the same industry are more expensive than BVS, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 96.74% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.26 | ||
| EV/EBITDA | 10.14 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as BVS's earnings are expected to grow with 25.05% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%
5. Dividend
5.1 Amount
- No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status for BVS stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 13.42 and the Price/Book (PB) ratio is 3.95.
What is the financial health of BIOVENTUS INC - A (BVS) stock?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.